The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

The data revealed that a combination of Escitalopram and Clonazepam was on top of the list, seeing an increase of 59.35% in sales since 2020.

Discover how mindfulness practices can provide anxiety relief rivaling antidepressants, offering a natural alternative with ...